Skip To Main Content
Kelley-Ross Pharmacy on Muck Rack

Kelley-Ross Pharmacy

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Kelley-Ross

Contact Kelley-Ross, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Patient-Focused Selection of PrEP Medication for Individuals at Risk of HIV: A Narrative Review

|
By Sheldon D. Fields, Elyse Tung, Kelley-Ross Pharmacy
| link.springer.com
Abstract Pre-exposure prophylaxis (PrEP) medication is a key component of the HIV prevention strategy in the US, which has been demonstrated to be highly effective in preventing HIV acquisition among individuals at risk. Two PrEP medications are currently approved: emtricitabine/tenofovir disoproxil fumarate (Truvada®; F/TDF) was approved by the US Food and Drug Administration in 2012, followed by emtricitabine/tenofovir alafenamide (Descovy®; F/TAF) in 2019.
Open in Who Shared Issue with article?
See all 1 articles